PG | Weekly | Haru Insights

Procter & Gamble’s $3.8 billion acquisition of Thorne marks a defining strategic pivot into the science-driven wellness and longevity space, signaling a bold departure from its traditional CPG model and a direct bet on Gen Z and millennial health-conscious consumers.
PG’s fiscal 2027 guidance includes $1 billion in after-tax cost headwinds—driven by raw materials, energy, transportation, and interest rates—projecting near-flat core EPS growth and underscoring severe near-term margin pressure despite strong underlying business momentum.

The Thorne acquisition is a transformative leap toward a high-growth, trust-based wellness ecosystem, positioning PG to capture digitally native consumers with clinical credibility and AI-powered personalization.
PG’s relentless execution on productivity and cost discipline, combined with a 70-year dividend growth streak and $15 billion annual shareholder return plan, reaffirms its status as a fortress of financial discipline and long-term reliability.
Leadership continuity through Shailesh Jejurikar’s consolidation of CEO and Chairman roles signals strategic stability, with proven momentum in AI integration, supply chain modernization, and margin management.
The move into the longevity and wellness space aligns PG with powerful secular trends, potentially unlocking a new revenue stream with double-digit growth potential and high customer lifetime value.
PG’s ability to execute large-scale transformations while maintaining shareholder returns demonstrates a rare balance of innovation and financial rigor, reinforcing investor confidence in its long-term vision.

The Procter & Gamble Company (PG)[Tv]